If it had merit, why wouldn't this be broadcasted EVERYWHERE and to EVERYONE.....?
These people would be interested:
They would be really interested!
".....topics from clinical trial design....." Cynata could present that you don't need to do that, you silly duffers in America.
Cynata would get everyone's attention.
Mesoblast isn't at this one because 20% C-level executives is too low brow. Mesoblast only deals with B and above. And Arizona might as well be the moon. This is povvo. It's the desert.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)